Latest Exchange Traded Funds News

Russell Investments Australian Responsible Investment ETF (ASX:RAR) reported a $304,000 loss for the year ended 30 June 2026, reversing a $69.892 million profit a year earlier. The fund still delivered a reported total return of 0.05% and lifted distributions to 168.11 cents per unit.

Global X Gold Bullion ETF reported a AUD 1.07 million loss for the year ended 30 June 2026, despite net assets rising to AUD 621.9 million. The fund also disclosed a lower management fee from September.

Global X Ultra Short Nasdaq 100 Complex ETF (ASX:SNAS) reported a $40.982 million loss for the year ended 30 June 2026, more than twice the prior year’s loss. Net assets still rose to $55.278 million as new applications outpaced redemptions, highlighting the difference between fund size and investor returns.

VanEck’s 13 ASX-listed ETFs produced sharply divergent FY2026 results, led by a $1.002 billion profit for Global Infrastructure and a $321.5 million gain for Gold Miners. Video Gaming and Esports moved the other way, reporting a $21.5 million loss, while International Wide Moat was subsequently overhauled and renamed.

Global X Ultra Long Nasdaq 100 Complex ETF delivered a sharply higher annual profit, driven largely by realised gains, but its net asset value has since fallen more than 10%. The result highlights both the attraction and the volatility of geared exposure to the Nasdaq 100.

Global X Artificial Intelligence ETF reported a sixfold increase in annual profit, driven overwhelmingly by gains in the value of its listed technology portfolio. Net assets more than tripled as investor applications and market gains lifted the fund to AUD 273.1 million.

VanEck’s nine ASX-listed equity ETFs produced sharply divergent FY2026 results, led by a $124.3 million profit at Small Companies Masters while Australian Equal Weight’s earnings fell heavily. The geared fund also reported a loss as borrowings nearly doubled to $48.6 million.

Global X Defence Tech ETF reported a $13.84 million loss for the year ended 30 June 2026, reversing a $7.50 million profit a year earlier. The result was driven by $14.48 million in net losses on investments and foreign exchange, even as investor applications lifted net assets to $112.56 million.

Perennial Better Future Active ETF will be voluntarily wound up after a $2.601 million loss and a sharp contraction in its unitholder base. The fund’s Responsible Entity says it is unlikely to achieve the scale needed to operate economically, with the process expected to finish in financial year 2027.

Global X S&P Biotech ETF (ASX:CURE) reported a AUD22.601 million profit for the year to 30 June 2026, reversing the prior year’s AUD2.863 million loss. The turnaround was driven overwhelmingly by gains in listed biotech securities and foreign exchange, rather than recurring income.

Global X S&P/ASX 200 Covered Call Complex ETF reported a sharp lift in annual profit as realised investment gains strengthened, while net assets passed $100 million. The fund declared 23.80 cents per unit for its June distribution, but its returns remain exposed to equity prices, options and a suspended holding valued at zero.

Global X Battery Tech & Lithium ETF delivered a sharply higher profit for the year ended 30 June 2026, driven by large fair-value gains across its listed equity portfolio. But the fund says its net asset value has since fallen by more than 10% as underlying battery and lithium investments weakened.